This week in a nutshell (31st January- 4th February)

Technical talks

NIFTY opened the week on 31st January at 17,301 and closed on 4th February at 17,516. It made a gain of 1.2% during the week. The index is trading below its 100DMA of 17,649 which might act as a resistance. On the downside, the 17,438 level might act as a support. The RSI (48), and MACD turning downward suggests a further possible decline.

Weekly highlights

  • The US indices closed the week in green as US state employment data was released which showed a drop in claims for unemployment benefits. During the week, the stocks buying picked up again. S&P 500 was up by 6%, Nasdaq 100 by 1.7%, and Dow Jones by 1.1%.
  • Adani Total Gas Ltd (ATGL), the joint venture between Adani Group and Total Energies of France, said that it will invest Rs 200 bn in setting up city gas infrastructure across the country over the next 8 years, with 60 percent of the money being used towards 14 licenses it won recently. With the addition of 14 geographical areas, it won in the latest bid round for city gas distribution (CGD) licences, Adani Total Gas now has a footprint in 95 districts spread across 12 states, catering to more than 9 mn households.
  • Bengaluru-based electric vehicle company Ather Energy will set up 1,000 fast charging stations for electric two-wheelers across Karnataka. The company plans to keep charging at these stations to be free of cost for everyone for first 1 or 2 years.
  • Meta’s (Facebook’s parent company) stock price fell by 26 percent on 3rd February after the company issued a weak forecast, citing Apple’s privacy changes and increased competition. The huge drop erased over $200 bn from Meta’s market capitalisation.
  • According to the commerce ministry, India’s eight core infrastructure sectors grew by 3.8 % in Dec-21, compared to 3.4 % in Nov-21. Natural gas and Cement were the largest contributors to an increased output in Dec-21 with 19.5% and 12.9% increase respectively.
  • The Centre’s fiscal deficit rose to 50.4% of the FY22 target in April-December 2021, with a huge increase seen in tax collections as well as capital expenditure for the month of December 2021, data released by the Controller General of Accounts showed. The Economic Survey for FY22, tabled on 31st January, said the Centre was well on track to meet its fiscal deficit target of 6.8 % of the Gross Domestic Product (GDP).
  • The ADP National Employment report showed that the private payrolls decreased by 301,000 jobs in Jan-22 after increasing by 776,000 in Dec-21. This was the first drop in private payrolls since Dec-20. The initial claims for state unemployment benefits dropped 23,000 to 238,000, suggesting that the slowdown in job growth in January was likely temporary.
  • FII (Foreign Institutional Investors) were net sellers of shares worth Rs 76,953 mn and DII (Domestic Institutional Investors) were net buyers of shares worth Rs 59,237 mn in this week.

Things to watch out for next week

  • As the budget 2022 announcement is behind us, we expect the budget-related volatility in the stock market to reduce in the next week.
  • With the announcement of government’s increased borrowing, and rising inflation, the monetary policy committee (MPC) meeting of RBI will be a key event to watch for the market next week.

Disclaimer: “The views expressed are for information purposes only. The information provided herein should not be considered as investment advice or research recommendation. The users should rely on their own research and analysis and should consult their own investment advisors to determine the merit, risks, and suitability of the information provided.”

Government’s focus on infra to invigorate strength of the economy

A key goal of the budget CY22 is in the execution of the Capex plan and crowding in private investment. The budget aims to stimulate the economy by beefing up public investments, creating demand for industrial inputs like cement, steel, and capital goods, and generating jobs. Finance minister Nirmala Sitharaman prioritized growth over fiscal reduction, increasing capital and infrastructure investment. In FY23, capital spending accounts for about 85% of the budget. The fiscal deficit target for FY23 has been set at 6.4 percent, a modest decrease from 6.9 percent in FY22.

The budget proposes a 35.4% increase in Capex, a 15% expansion of the national highways network with the addition of 25,000 km of roads, the development of four multimodal logistics parks in the coming year, a focus on electric vehicle (EV) charging infrastructure, and a new battery swapping policy. It also suggested a 7.5% customs tax decrease for all project capital goods imports over time, as well as a budget commitment of Rs 19.5 bn for the production-linked incentive (PLI) plan for polysilicon solar module manufacturing. The divestment target is reasonable at Rs. 68 bn in FY23, down from Rs. 78 bn in FY22. The initial public offering (IPO) of LIC, which is expected in March 2022, will meet this divestment goal. The government intends to sell a 5% stake in the company to raise Rs. 75 bn, with considerable demand, predicted from both retail and institutional investors. LIC IPO is not only expected to facilitate the huge influx of retail investors into the Indian equity markets but also expected to reduce the money flows in different sectors.

The FED’s liquidity normalization initiative has gained traction and market interest rates have risen as a result of this. This is projected to normalize the returns from different asset classes, including equities. The Indian equity market saw exit by the foreign institutional investors in the last few months, mainly because the US has entered a phase of aggressive liquidity normalization and rising interest rates. It is the high rate of economic growth and the accompanying high level of inflation that has led to the policy modifications in the US. However, the government’s private investment policy encounters a significant hurdle a massive tightening of borrowing costs in the economy. The expectation was that the RBI will keep its accommodative policy stance until the economy is fully recovered. With the budget announcement, however, the RBI is expected to hike its policy rates.

As the liquidity reduces, financing large deficits becomes difficult in rising interest rates scenario which dampens the returns from equities. We believe that sectors such as defense (which has been allocated 13.3% of the total budget with a focus on indigenization), infrastructure, metals, cement, and ancillaries are expected to remain in the spotlight with a particular emphasis on firms with low PE multiples.

Disclaimer: “The views expressed are for information purposes only. The information provided herein should not be considered as investment advice or research recommendation. The users should rely on their own research and analysis and should consult their own investment advisors to determine the merit, risks, and suitability of the information provided.”

Product Specific Price Erosion in US Markets – Sun Pharma


Update on the Indian Equity Market:

On Thursday, NIFTY closed in the red at 17,560 (-1.2%). Among the sectoral indices IT (-2.1%), REALTY (-1.7%), and FINANCIAL SERVICES (-1.4%) were top losers, and AUTO (+0.4%) and CONSUMER DURABLES (+0.1%) were sectoral gainers. HEROMOTOCO (+2.3%), BAJAJ-AUTO (+2.1%) and DIVISLAB (+0.9%) were the top gainers. HDFC (-3.5%), ONGC (-3.0%), and SBILIFE (-2.9%) were among the top losers.

Excerpts from an interview of Mr. CS Muralidharan, CFO of Sun Pharma, with CNBC-TV18 dated 02nd February 2022:

  • The government’s focus on healthcare initiatives and push for modernisation in the Union Budget 2022 bodes well for the industry, the incentive for manufacturers is something to look for considering the medium-term horizon.
  • US Specialty Revenues for 9MFY2022 exceeded full-year FY2021 Revenues, the growth in revenues was fuelled by contribution from all the products. Winlevi was recently launched in the US in November 2022 is showing good traction.
  • The company is on a very good footing now because they have been focusing on increasing their prescription of core products which has helped the company record good growth in the global specialty business.
  • The company is now increasing its geographical presence across the globe as a part of the strategy to leverage its pipeline across global markets, it recently launched its Derma-Specialty products Illumya and Cequa in Canada which is seeing good traction.
  • Price Erosion in the US has been a product-specific issue for the company as compared to its other peers which have seen pricing erosion across the board. The company has seen pricing erosion in the ex-Taro generic business but it has managed to control the same by leveraging new launches and efficient supply chain management.
  • Global uncertainty around COVID-19, especially the caseload in the US has impacted the company’s ability to give guidance over the medium term. The company has plans to continue its growth momentum by focusing on specialty revenues and Indian business and the rest of the world emerging markets.
  • EBITDA margins are seeing some pressures due to rising costs. However, the company has reiterated that margins will say stable due to increased operational efficiencies and cost-saving measures.
  • Despite strong competitive pressures, the company has consistently managed to improve its market share in the domestic business and outperform the industry growth by a large margin.

Asset Multiplier comments:

  • US Generic Business has been seeing competitive pricing pressures for all pharma manufacturers. Sun Pharma has effectively managed to mitigate pricing pressures due to prudent policies.
  • Domestic India and the Rest of the World Emerging Market Business has seen good traction in the past few quarters, Sun Pharma can leverage its presence to unlock the next stage of the growth cycle in these markets.

Consensus Estimate: (Source: Market screener website)

  • The closing price of Sun Pharma was ₹ 885/- as of 03-February-2022.  It traded at 28x/25x/22x the consensus Earnings per share estimate of ₹ 32/35/40/- for FY22E/FY23E/FY24E respectively.
  • The consensus average target price is ₹ 972/- which implies a PE multiple of 24x on FY24E EPS of ₹ 40/-.

Disclaimer: “The views expressed are for information purposes only. The information provided herein should not be considered as investment advice or research recommendation. The users should rely on their own research and analysis and should consult their own investment advisors to determine the merit, risks, and suitability of the information provided.”

 

Margin pressure due to the increased marketing spending – Info Edge

Update on the Indian Equity Market:

On Wednesday, NIFTY closed in the green at 17,780 (+1.2%). Among the sectoral indices, PSU BANK (+3.4%), PRIVATE BANK (+2.3%), and BANK (+2.1) were the top gainers. There were no sectorial losers for the day. BAJAJFINSV (+5.0%), INDUSINDBK (+5.0%), and HCLTECH (+3.5%) were the top gainers. TECHM (-1.4%), ULTRACEMCO (-1%), and BRITANNIA (-0.9%) were among the top losers.

Excerpts from an interview of Mr. Chintan Thakkar, Wholetime Director and CFO at Info Edge with CNBC TV18 dated 31st January 2022:

  • The real way to look at the numbers is to look at the billing as well as cash EBITDA. The revenue is coming from the billings that happened in the 2QFY22, the billings are almost collected, and it’s an all-cash collection.
  • The overall margins are impacted due to an increase in spending on marketing and advertising expenses. The company is investing in its platforms, Jeevansathi, and in 99 acres. In 3QFY22, the Company’s EBITDA margin and PBT were impacted due to the increased spending in marketing and advertisement expenses in Jeevansathi and 99 acres.
  • The biggest growth driver for the company is recruitment solutions. There it has not increased its marketing spend in absolute numbers and the increase is marginal.
  • 3QFY22 was a strong quarter from a margins standpoint, particularly from the recruitment side. The strong momentum started from 3QFY21 has continued to do well. The increase in momentum is with the building up in the recruitment business and the company expects upside trend over there.
  • The overall paid listing has gone up on 99 acres. Increasing paid listing rather than the free listing is a part of the company’s overall strategy .
  • Info Edge started reinvesting in the real estate segment which was affected in FY21 due to the pandemic and the company expects the uptrend in the real estate business and has increased its spending as compared to last year.
  • On startup investment he said, the startup ecosystem is very vibrant and Info Edge also invests in the startups ecosystem as the company knows how the mechanism works there.
  • Info Edge continues to innovate and improve and is also investing in their products for the future growth of the company.
  • The company is focused on efficient growth on the top line as well as on the margins front. Other than that, the company invests in some of the startups and takes stake over there for the future growth of the company which is part of their overall strategy. The Company is balancing between current growth as well as the future growth of the company.
  • The company is seeing continued momentum and the company has not seen any major impact of omicron on the business and expects the 4QFY22 to also be a good quarter.

Asset Multiplier comments:

  • We believe that as the economic activities recover, the real estate sector will grow at a significant rate as well the robust hiring activities would support the revenue growth and positive operating leverage should support margins in the near term.
  • We expect the company’s investments in the startups to scale up in the near term and start contributing to the company’s valuation.

Consensus Estimate: (Source: TIKR website)

  • The closing price of Info Edge was ₹ 5,114/- as of 2-February-2022.  It traded at 143x/129x/125x the consensus Earnings per share estimate of ₹ 35.8/39.6 /40.9/- for FY22E/FY23E/FY24E respectively.
  • The consensus average target price is ₹ 5,648/- which implies a PE multiple of 138x on FY24E EPS of 40.9/-.

Disclaimer: “The views expressed are for information purposes only. The information provided herein should not be considered as investment advice or research recommendation. The users should rely on their own research and analysis and should consult their own investment advisors to determine the merit, risks, and suitability of the information provided.”

Expect cost inflation of 4-5% to continue – Diageo India (United Spirits)

Update on the Indian Equity Market:

On Tuesday, Nifty closed higher at 17,576 (+1.4%). METAL (+4.5%), PHARMA (+2.3%), and HEALTHCARE (+2.2%) were the top gainers while AUTO (-0.8%), OIL & GAS (-0.7%), and PSU BANK (-0.6%) were top losing sectors.

The top gainers were TATASTEEL (+7.5%), SUNPHARMA (+6.9%), and INDUSINDBK (+6.1%) while BPCL (-4.5%), IOC (-2.8%), and TATAMOTORS (-2.6%) were the top losers.

Edited excerpts of an interview with Ms. Hina Nagarajan, Managing Director, and Chief Executive Officer, Diageo, India with CNBC TV18 on 31st January 2022:

  • The company’s management is focused on sustaining the present demand momentum, and it is dedicated to providing a sustained double-digit growth rate in terms of volume.
  • The management expects cost inflation of 4-5 percent to continue in the future. The company experienced 2.5 percent portfolio inflation, which was offset by a favorable product mix, and operational savings. The ethanol blending pricing strategy and grain price rises have had an influence on extra neutral alcohol (ENA), which was previously flat.
  • The company is in the process of submitting price raise proposals to state governments in order to combat inflation.
  • Through the value chain, revenue management levers of the mix, and trade efficiency, the organization is focusing on productivity.
  • On the EBITDA margin front, which is now in the 16-17 percent range, management is sticking to its mid to upper teen guidance. In the long run, the company aims to achieve and maintain high teen margins.
  • The company is confident in its ability to attain mid-high teen margins and is unwilling to accept any levels below those specified.
  • In terms of competition, the company is doing well in their super-premium portfolio, but there is some aggressiveness from their competitors. However, management claims that the company is well-positioned to take advantage of the premiumization trend and that the portfolio’s innovation and renovations will drive growth for the category.
  • Consumers have reacted well to their innovations and renovations in the signature and Blackdog categories, and the launch of Royal Challenger American Pride, an American bourbon-based whiskey, has received excellent feedback.
  • The scotch category, which accounts for 20 to 24 percent of overall sales, is rapidly expanding. Scotch is expected to be a major growth driver in the future.

Asset Multiplier Comments

  • We expect improving regulatory environment, investment in ad spends, adoption of home delivery trend will help bring in topline growth.
  • Improved product mix due to premiumization and cost saving efforts will help achieve company’s EBITDAM guidance of mid to high teens.

Consensus Estimate (Source: market screener website)

  •  The closing price of UNSP was ₹ 884 /- as of 1-February-2022. It traded at 68x/ 55x/ 44x the consensus earnings estimates of ₹ 13/ 16/ 20 for FY22E/FY23E/FY24E respectively.
  • The consensus target price of ₹ 954/- implies a P/E Multiple of 48x on FY24E EPS estimate of ₹ 20/-.

Disclaimer: “The views expressed are for information purposes only. The information provided herein should not be considered as investment advice or research recommendation. The users should rely on their own research and analysis and should consult their own investment advisors to determine the merit, risks, and suitability of the information provided.”

 

 

New launches to offset US pricing pressure- Cipla

Update on the Indian Equity Market:

On Monday, NIFTY closed in the green at 17,339 (+1.4%) ahead of the Budget. Among the sectoral indices, REALTY (+3%), PSU BANK (+3%), and IT (+2.8%) were the top gainers and there were no sectoral losers. TECHM (+5.2%), TATAMOTORS (+4.0%), and WIPRO (+3.8%) were the top gainers. INDUSINBK (-3.5%), KOTAKBANK (-2.0%), and COALINDIA (-1.4%) were among the top losers.

Excerpts from an interview of Mr. Umang Vohra, MD & Global CEO, Cipla (CIPLA) with Economic Times dated 31st January 2022:

  • On the India growth numbers, CIPLA saw strong momentum in the base portfolio and has pre-allocated resources to the bigger brands. As healthcare begins to expand, it saw a large contribution from Tier 1 to 4 towns to the volume growth. It has re-positioned resources on its key branded franchises in India on the back of consumer business playing out strongly.
  • In the US, CIPLA’s respiratory portfolio gained market share resulting in revenues worth US$150 mn. Mr.Vohra said the December quarter always has bunched up sales because that is the buying pattern in the US as there are holidays in the first 7-8 days of January.
  • Launch momentum is going to be significant in FY23 because the US is responsive to it.
  • In South Africa, the market is divided into private and tender. The tender is linked to government buying. The private market has always shown robust growth and CIPLA has been beating the market over the past five years QoQ.
  • There were congestions in the tender market as there are patterns of government buying in response to the Budget of the country. These patterns respond to the aid that the country receives in terms of a portfolio of medicines, in terms of the buying agencies supporting the various governments.
  • The South African tender market is going through a new cycle similar to the one 3 years ago. Despite some shifts due to this cycle, it is expected to go back to the way it was originally.
  • In India, CIPLA sees doctor practice to come back strongly on the back of volume demand.
  • Pricing pressure in the US is expected to continue. It is the nature of the US market. It is a free market and prices fall as more players enter it. CIPLA has responded to these pressures quite significantly and these are expected to continue going forward.
  • The issue of pricing will be there in the US markets but new launches are expected to offset that.

Asset Multiplier comments:

  • The US business is expected to ramp up on the back of new launches and a complex generics portfolio.
  • The revenues were not impacted significantly by US price erosion due to new complex launches and increasing market share. Should the new launches get delayed, CIPLA will be impacted by the pricing pressures in the US.
  • With the decline in COVID-19 products’ contribution, the base portfolio has started growing. We expect this base portfolio to perform well in the coming quarters as the cases start declining.
  • We expect margins to sustain the upward trajectory for the next few quarters as the complex pipeline is strong.

Consensus Estimate: (Source: Market screener and Tikr websites)

  • The closing price of Cipla was ₹ 945/- as of 31-January-2022.  It traded at 27x/23x/20x the consensus earnings per share estimate of ₹ 35/42/50/- for FY22E/FY23E/FY24E respectively.
  • The consensus average target price is ₹ 1,088/- which implies a PE multiple of 22x on FY24E EPS of ₹ 50/-.

Disclaimer: “The views expressed are for information purposes only. The information provided herein should not be considered as investment advice or research recommendation. The users should rely on their own research and analysis and should consult their own investment advisors to determine the merit, risks, and suitability of the information provided.”

This Week in a Nutshell (24-28 Jan)

Technical talks

NIFTY opened the week on 24th January at 17,572 and ended at 17,102 on 28th January. NIFTY fell 2.9% throughout the week, forming a bearish engulfing candle on the weekly chart. The next support and resistance levels for the index would be 16,840 and 17,635 respectively.

Except for PSU BANK (+6.9%), and Bank (+0.3%), all the sectoral indices fell this week, with IT (-6.1%), Realty (-5.2%), and Infra (-2.4%) being the biggest losers.

Weekly highlights

  • Financial markets started the week on a volatile note on the back of fears of monetary tightening as the Fed announced that they would start raising interest rates. Nevertheless, volatility intensified with erratic stock movements amid shaky company earnings cast doubt on the strength of the recovery from the COVID-19 pandemic. The US stocks closed the week in the green, S&P up 0.8% and Nasdaq up 0.1%.
  • Equity markets in India also witnessed volatility during the week due to the ongoing results season, the Fed meeting, and mixed budget expectations.
  • Continual commodity cost rise is creating pressure on margins across the board especially FMCG, consumer, and chemical companies. To sustain margins and maintain topline growth, companies have implemented price increases in conjunction with cost-cutting strategies.
  • On 26th January, US Federal Reserve Chairman Jerome Powell announced that the US job market was robust enough to absorb rate rises and that the current tightening cycle would be different from previous ones. The Federal Reserve is expected to raise interest rates in March-22 and maintain plans to conclude its bond-buying program that month to keep inflation under control.
  • Oil prices on 27th January hit a seven-year high, Brent crude was above $90 a barrel, as the market balanced concerns about tight worldwide supply amid Russia- Ukraine tensions and the expectations that the US Federal Reserve will soon tighten monetary policy. Closing prices of Brent crude futures and WTI crude futures were $89 and $87.3 per barrel respectively as on 29th January 2022.
  • The US gross domestic product (GDP) grew at 6.9% higher than the Dow Jones estimate of 5.5%, coming back from a brief but severe coronavirus recession in 2020. It was the best calendar-year growth rate since 1984.
  • The Tata group formally took over Air India on January 27th, 67 years after the group founded the airline in 1932.
  • The foreign institutional investors (FII) continued to be sellers and sold equities worth Rs 202,640 mn. Domestic institutional investors (DIIs) continued to be buyers and bought equities worth Rs 77,600 mn.

Things to watch out for next week

  • Market participants expect the Union Budget would not throw any surprises at investors, sticking to the expected narrative of fiscal restraint and growth as the fiscal deficit is expected to fall below pre-covid levels, and the government’s push for infrastructure capex and privatization. Analysts at Morgan Stanley anticipate the government will focus on gradual fiscal consolidation while driving public capex, fostering a favorable climate for private capex, and generating resources through selective divestments.
  • Contrary to international investors, retail customers are entering the Union Budget with net long holdings on the Nifty 50’s February futures of 68,592 contracts.
  • Markets will react to earnings reported by consumer companies like Marico and Britannia. Companies such as Tech Mahindra, Dabur, HDFC, Tata Motors, Cadila Healthcare, and Lupin are set to report earnings next week. The management commentary on price erosion in the US market will be key for pharma companies. Comments on raw material inflation and logistical challenges will be key for consumer companies.
  • Capital goods, infrastructure, housing, real estate, public sector banks are likely to be in the spotlight ahead of the Budget.

Disclaimer: “The views expressed are for information purposes only. The information provided herein should not be considered as investment advice or research recommendation. The users should rely on their own research and analysis and should consult their own investment advisors to determine the merit, risks, and suitability of the information provided.”

 

 Expect NIMs to be in the range of 3.2-3.3% – Federal Bank

Update on the Indian Equity Market:

On Thursday, Nifty closed lower at 17,110 (-1%) in the highly volatile session after Federal Reserve in its policy outcome indicated interest rates hike soon.

PSU BANK (+5.1%), BANK (+0.7%), and MEDIA (+0.6%) were the top gainers and IT (-3.6%), CONSUMER DURABLES (-2.3%), and HEALTHCARE INDEX (-2.3%) were top losing sectors.

The top losers were HCLTECH (-3.9%), TECHM (-3.6%), and DRREDDY (-3.4%) while AXISBANK (+3.3%), SBIN (+2.8%) and CIPLA (+2.3%) were the top gainers.

 Expect NIMs to be in the range of 3.2-3.3% – Federal Bank

Edited excerpts of an interview with Mr. Shyam Srinivasan, Managing Director and Chief Executive Officer, Federal Bank with ETNow on 25th January 2022:

  • In 3QFY22, Federal Bank’s advances grew by 4.5% QoQ and 12% YoY. 3QFY22 showed all-around improvement. The performance was broad-based which is an encouraging sign. Some businesses were driven by economic activity and the bank’s gain in market share.
  • In 3QFY22:
    • Corporate business come back strongly, and
    • Retail, which has been trending well, gathered steam and kept its pace with the developments in the economy.
  • The overall numbers show credit growth and improvement in the quality of the book.
  • The credit quality of the Bank is normally in the top quartile and credit costs have been well managed across lengths of time because of disciplined lending.
  • In 3QFY22, Federal Bank recorded its best-ever net profit and ROA crossed 1%. It crossed the Rs 5,000 mn quarter mark in net profits. So, it has been a diversified, broad-based, and on-target performance.
  • Generally, Bank’s performance is ahead of the industry by a multiple. As the economy picked up pace in 3QFY22, Federal Bank saw a good pick up and its market share gain amplified. The bank is witnessing organic, structural, and holistic growth and it is not one-off bolstering performance.
  • The bank is confident of continuing its momentum in 4QFY22E provided the economy is moderately affected by Coronavirus third wave.
  • The bank believes that green shoots in the economy should play through and if it does, the bank’s market share gain will be even more pronounced.
  • Looking at the last two-three years of the incremental credit in the country, the bank’s share is higher than its normal market share.
  • The bank is gathering momentum across and believes as things improve in the economy, its market share gain should be visible across the spectrum.
  • The credit cost of the bank has reached its bottom at 22 bps and there is no scope for further improvement. Mr. Srinivasan thinks that a normalized credit cost on an annualized basis of around 50-60 bps in a steady state would be a good place to be in. The bank always tries to maintain a balance between the kind of business momentum, and credit cost.
  • Recovery upgrade for 3QFY22 was strong and close to Rs 3,000 mn. Slippages in 3QFY22 were Rs 3,300 mn and almost matched the slippages of the 2QFY22. The incremental recovery upgrades are doing well, and collection efficiency is strong.
  • The CEO expects to see a pick up in capex in 2HCY22 as capacities are getting built-in.
  • Bank’s share gain is visible as it doesn’t have the baggage of any adverse credit and companies are beginning to look at borrowing opportunities. For a greater part of CY21 corporates had other borrowing opportunities to meet their credit requirements but those are turning out to be a little more expensive. So, banking and bank credit are looking more attractive and as that happens, Federal Bank is well-positioned to gain share.
  • Sequentially, the corporate book grew ~7% in 3QFY22. The bank is confident that this will repeat as its strengths, reach out programs and appetite remains strong. Bank thinks as capex picks up, the corporate book will grow even faster.
  • The Bank has been giving NIMs guidance to be in the range of 3.2% to 3.3%. The bank is presently at 3.27% levels and sees room for improvement of another 5 odd basis points.
  • NIMs are impacted by the mix of the book, frequency of credit growth, the quantum of credit growth, and reversals in slippages. Bank has successfully controlled all these variables and demonstrated NIMs expansion. Typically, in a rising interest rate scenario, NIMs tend to expand for banks.

Asset Multiplier Comments

  • We think the Bank’s performance in terms of the advances growth, profitability, and asset quality has been strong.
  • We expect this momentum to continue considering the improving economic condition which will aid higher disbursements and better asset quality.

Consensus Estimate (Source: market screener website)

  •  The closing price of Federal Bank was ₹ 100/- as of 27-January-2022. It traded at 1.08x/0.98x/ 0.87x the consensus Book Value Per Share estimates of ₹ 88.4/ 98.1/ 110 for FY22E/FY23E/FY24E respectively.
  • The consensus target price of ₹ 118/- implies a PBVPS Multiple of 1.07x on FY24E BVPS estimate of ₹ 110/-.

Disclaimer: “The views expressed are for information purposes only. The information provided herein should not be considered as investment advice or research recommendation. The users should rely on their own research and analysis and should consult their own investment advisors to determine the merit, risks, and suitability of the information provided.”

 

 

 

The upward trajectory in VNB margin to continue – HDFC Life

Update on the Indian Equity Market:

On Tuesday, NIFTY50 snapped its five-day losing streak amid a volatile session. The index closed at 17,278 (+0.8%) as investors await more financial results in India and the outcome of the Fed Reserve meeting scheduled on Wednesday.

Among the sectoral indices, PSU BANK (+4.2%), AUTO (+2.3%), and MEDIA (+2.2%) led the gainers. IT (-0.3%) was the only sector which ended in the red. Among the stocks, MARUTI (+7.4%), AXISBANK (+6.5%), and SBIN (+3.9%) led the gainers while WIPRO (-1.6%), BAJAJFINSV (-1.4%), and TITAN (-1.2%) led the laggards.

Excerpts from an interview of Ms. Vibha Padalkar, MD& CEO, HDFC Life with Economic Times dated 24th January 2022:

  • HDFC Life reported 3QFY22 earnings, and all channels reported growth. In terms of the product mix, after 2 quarters’ lull, the individual protection grew by 20% YoY. Annuity continues to do well and reported 39% YoY growth.
  • On a standalone basis, the VNB margin (a profitability measure) has increased from 26.4% to 26.8% due to higher volumes and a balanced product mix. The CEO believes the upward margin trajectory will continue.
  • COVID-19 claims have reduced significantly in 3QFY22. From the peak of Rs 3,000mn claims in 2QFY22, the claims were reduced to Rs 170mn in 3QFY22. Due to the ongoing Omicron wave, the company has strengthened its mortality reserves and is carrying Rs 1,550mn of extra reserves.
  • The company has hiked its prices by 15-25%, which it believes was necessary. While the retention amount has increased, there was no impact on the solvency as reserves were carried at higher levels. Ms. Padalkar believes that price hikes for life insurance products and health insurance products are bound to happen due to inflation.
  • The solvency ratio was 190% before the cash payout for the Exide Life acquisition. The solvency was over 200% in 3QFY21, which was more of an aberration. The company maintains solvency in the 190-195% zone. She expects profits generated in 4QFY22 will add to the solvency of the company. Second, they have raised Rs 6,000mn as subordinated debt. If the need be, they can increase the subordinated debt levels.
  • The first step of the Exide Life merger with HDFC Life is complete. The next step is about 9months to a year away when the full integration happens and HDFC Life will be able to enjoy synergies. It will add 30-35% to the company’s agency channel and deepen its presence in South India and tier two and three towns.
  • The CEO believes the third wave has peaked in several parts of India indicating demand and all the macro indicators are robust. People’s attitude towards insurance has changed.
  • A lot of people reaching retirement age are thinking about getting annuity plans as they realise they will outlive their retirement age by ~20 years or more. The company’s retirement focus campaigns are also enlightening people.
  • The company is very close to its ideal product construct which is about a third unit-linked, about third participating products, and the balance non-participating savings products.

Asset Multiplier comments:

  • The insurance sector is a multi-decadal opportunity in India due to the under penetration and protection gap.
  • We believe the Company has maintained significant provisions to provide for claims expected due to the third wave. This coupled with a dynamic and balanced business mix, protection business strategy, and the expected pickup in agency business augurs well for the growth of the company.

Consensus Estimate: (Source: Market screener website)

  • The closing price of HDFC Life was ₹ 630/- as of 25-January-2022.  It traded at 94x/ 72x/ 62x the consensus EPS estimate of ₹ 6.7/ 8.7/ 10.2/- for FY22E/FY23E/FY24E respectively.
  • The consensus average target price is ₹ 787/- which implies a PE multiple of 77x on FY24E EPS of 10.2/-.
  • In the case of life insurance companies, the embedded value per share is the correct multiple for valuing the company. The consensus estimate of this metric is not available on any of the websites.

Disclaimer: “The views expressed are for information purposes only. The information provided herein should not be considered as investment advice or research recommendation. The users should rely on their own research and analysis and should consult their own investment advisors to determine the merit, risks, and suitability of the information provided.”

Inflationary headwinds reducing, topline growth outperforms – Asian Paints



Update on the Indian Equity Market:

On Monday, NIFTY closed in the red at 17,149 (-2.7%). Among the sectoral indices REALTY (-5.9%), METAL (-5.2%), and MEDIA (-4.6%) were top losers, and there were no sectoral gainers. CIPLA (+2.9%), and ONGC (+0.9%) were the only gainers. BAJFINANCE (-6.4%), JSWSTEEL (-6.9%), and TATASTEEL (-5.9%) were among the top losers.

Excerpts from an interview of Mr. Amit Syngle, MD & CEO, Asian Paints with Economic Times dated 21st January 2022:

  • In 1HFY22 the company had taken a 7% hike and in Q3FY22, they had already taken two hikes in November and in December totaling about 15%. Quarter on quarter, the company had a very strong volume growth at 18% and value growth of 26%.
  • With a healthy topline growth quarter on quarter, the margins have gone up because of the price hike which has been taken and so has the EBITDA margins being impacted in a very strong way.
  • The company is on a very good footing now because they have taken the pressure of inflation head-on and raised prices to the tune of about 22% for the year so far. The next quarter looks good from the point of view of addressing the inflation by the company.
  • The price increases have been unprecedented. Notwithstanding that, the company has seen quite a strong volume growth as well as value growth because October and November were very good for the company given the festive period.
  • The COVID-19 pressure was off to that extent, the consumer sentiment was quite good even in December. The company got a little bit hit in the second fortnight of December because of the third wave emerging but overall the company saw very healthy volumes, very good value growth. The company has gained a good quantum of market share in the third quarter as seen forward.
  • People have been experiencing COVID for the last year and nine months and the experience has been that there is an impact on consumer sentiment, which happens immediately when such a wave starts. But overall, there is only a little bit of a deferment of sales because people do not put off their painting or the renovation cycles.
  • The company’s outlook is that while in January there might see some impact of price hike and COVID-19, going forward, in February and March, it expects to see recovery with sales coming back strongly.
  • Going forward, it sees the environment as still inflationary. Despite taking price hikes or the crude hitting high prices and as prices of some of the crude derivatives go higher, some prices of select raw materials might come down. So overall, it expects the impact of Q4 over Q3 to be mild but the environment would remain inflationary.

Asset Multiplier comments:

  • Asian Paints has been an undisputed market leader in the paints category, despite inflationary near-term headwinds. We believe the company is likely to outperform based on its strong brand image and execution capabilities.
  • The expected boom in real estate augurs well for the company as we are entering a multi-year cycle of developmental activity that’ll help the top line of the company.

Consensus Estimate: (Source: Market screener website)

  • The closing price of Asian Paints was ₹ 3,155/- as of 24-January-2022.  It traded at 93x/67x/55x the consensus Earnings per share estimate of ₹ 34/47/57/- for FY22E/FY23E/FY24E respectively.
  • The consensus average target price is ₹ 3,380/- which implies a PE multiple of 59x on FY24E EPS of ₹ 57/-.

Disclaimer: “The views expressed are for information purposes only. The information provided herein should not be considered as investment advice or research recommendation. The users should rely on their own research and analysis and should consult their own investment advisors to determine the merit, risks, and suitability of the information provided.”